The renal haemodynamic and excretory actions of prostacyclin and 6-oxo-PGF1 alpha in anaesthetized dogs

Prostaglandins
T W Hill, S Moncada

Abstract

Intrarenal arterial (i.a.) infusions of prostacyclin (PGI2) at 30-300 ng/min to anaesthetized dogs reduced renal vascular resistance (RVR) and filtration fraction (FF), increased mean renal blood flow (MRBF) but did not alter mean arterial pressure (MAP)or glomerular filtration rate (GFR). The urinary excretion of sodium (UNaV), potassium (UKV) and chloride ions (UC1V) were increased through inhibition of net tubular ion reabsorption. PGI2 (3000 ng/min, i.a.) reduced MAP and increased heart rate. Intravenous (i.v.) infusions of PGI2 (3000 gn/min) reduced MAP, GFR, FF, urine volume and ion excretion, with elevation of heart rate. The measured variables were unaltered by 6-oxo-PGF1 alpha (10,000 ng/min i.a.). Treatment of the dogs with the PG synthetase inhibitor meclofenamic acid (2.5 mg/kg i.v.) did not antagonise the elevation of MRBF to PGI2 (300 ng/min i.a.). Thus the renal effects of PGI2 were due to a direct action rather than through conversion to 6-oxo-PGF1 alpha or through stimulation of endogenous renal PG biosynthesis and release.

References

Jun 16, 1977·Nature·P M BolgerL M Slotkoff
Jan 1, 1975·Circulation Research·J TannenbaumA S Nies
Sep 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·G R MarchandH E Williamson
Mar 1, 1974·European Journal of Pharmacology·C Larsson, E Anggård
Nov 1, 1971·Medical & Biological Engineering·R Hughes

❮ Previous
Next ❯

Citations

Jan 1, 1986·Prostaglandins, Leukotrienes, and Medicine·B LangkopfW Förster
Jan 1, 1987·Hearing Research·E FerraryB Escoubet
Apr 27, 1999·British Journal of Pharmacology·E Raczka, A Quintana
Dec 16, 1998·Kidney International·C D ThronL C Ou
Jan 4, 2001·The Journal of Small Animal Practice·S F ForsythD U Pfeiffer
Dec 1, 1982·Archives of Disease in Childhood·G B HaycockC Chantler
Jun 1, 1980·Prostaglandins·A SzczeklikR Nizankowski
Jan 1, 1983·General Pharmacology·L BrandtT Uski
Feb 1, 1982·The American Journal of Medicine·D J LevensonB M Brenner
Sep 13, 2005·Cell Metabolism·Helene FrancoisThomas M Coffman
Feb 1, 1992·The American Journal of the Medical Sciences·E E MuirheadL W Byers
May 1, 1994·Kidney International·S NatovT P Hannedouche
Jan 1, 1985·Medicinal Research Reviews·R C NickolsonH Vorbrüggen
Jan 1, 1983·British Journal of Clinical Pharmacology·M Verstraete
Feb 12, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Steven D CrowleyPhillip Ruiz
Jun 1, 1996·Gastroenterology Clinics of North America·M J Ruwart, K S Henley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.